Australian Health Minister Greg Hunt announced the National Strategic Action Plan for rare diseases. Imfinzi has been added to the PBS for non-small-cell lung cancer. A common gut bacterium may contribute directly to colorectal cancer, in a discovery by Hubrecht Institute researchers. Research led by QIMR, involving 278 institutions from around the world, has concluded 191 genes are likely to affect a woman’s risk of developing breast cancer. A collaboration between Brisbane and Melbourne universities has shown a blood test using nanotechnology can identify signals released by cancer cells. | | Wednesday 26 February - Monday 2 March | | | Bendigo Advertiser (Licensed by Copyright Agency) • Feb 29, 2020 7:0 | | Growing up, Jenna Sing didn't want to become a nurse. A trip to Bendigo Health's oncology ward in Year 12 changed... programs undertaken at the Olivia Newton John Cancer Centre and Peter MacCallum Cancer Centre. Ms Sing said the notion of wellness... |
|
| | Science Media Exchange - Scimex • Feb 28, 2020 3:23 | | Being exposed to a specific strain of the common gut bacteria Escherichia coli may contribute to colorectal cancer, according to... Common gut bacteria E. coli linked to colorectal cancer |
|
| | https://www.nationaltribune.com.au • Feb 27, 2020 7:38 | | An international study, co-led by Queensland researchers, has concluded that 191 genes are likely to affect a woman’s risk of developing... a woman’s risk of developing breast cancer. The research – led by QIMR Berghofer Medical Research Institute,... |
|
| | Science Media Exchange - Scimex • Feb 27, 2020 6:3 | | A novel blood test that uses gold nanoparticles to detect cancer has also been shown to identify signals released by cancer cells which... specific to the patient. With the help of the collaborators at the ONJCRI, the technology was tested on blood samples from 23... |
|
| | The Age (Licensed by Copyright Agency) • Feb 26, 2020 22:27 | | Rhonda Lumsden was suffering from stage 4 lung cancer and out of options, when a new drug gave her a second chance.... New drug added to PBS to help treat Australia's deadliest cancer |
|
| | The Conversation [AU] • Feb 26, 2020 14:10 | | Disclosure statement Yvonne Zurynski receives funding from NHMRC, ARC, The Sax Institute. If you have a rare disease, you may be... to boost research in Australia. In 2019 the NHMRC and the Medical Research Future Fund pledged A$15 million over five years for... |
|
|
|
|
|
|